I
n cardiomyocytes, the generation of ATP primarily occurs in the mitochondria, which are separated from ATPconsuming sites in the myofibrils. 1 To ensure communication between sites that generate and use ATP, it has been hypothesized that cells rely on phosphotransfer networks that facilitate the transfer and distribution of energy-rich phosphoryls between cellular compartments in a kinetically and thermodynamically efficient manner. [2] [3] [4] [5] [6] [7] Several studies have indicated that most phosphoryls are transferred through multiple creatine kinase-catalyzed phosphoryl exchanges that involve creatine phosphate and ATP. 8 -11 In fact, this enzyme is essential in supporting cardiac bioenergetics, 5, 7, 10, 12 and a decrease in energy reserve due to abnormalities in creatine kinase may contribute to heart failure. [13] [14] [15] However, neither the suppression of creatine kinase activity 7 nor the disruption of genes that encode the cytosolic and mitochondrial creatine kinase isoforms 6,16 -20 produce overt ventricular dysfunction. This suggests that alternative phosphotransfer routes may also support cardiac function. The identity of such phosphotransfer systems and their contribution to myocardial bioenergetics in the normal or failing heart remain unknown.
A candidate enzyme is adenylate kinase, 4, [21] [22] [23] which in skeletal muscle can transfer from 3% to 23% of the highenergy phosphoryls, which depends on the functional load of the muscle. 8, 22, 24 This enzyme catalyzes the reversible reaction 2ADP7ATPϩAMP and may process metabolic signals associated with ATP use. 2, 4, 21, 26, 27 In this case, adenylate kinase has been implicated in the regulation of metabolically sensitive ion channels and transporters. 3,28 -30 In addition, disruption of the adenylate kinase gene impedes the export of ATP from the mitochondria. 31 Although in the heart, isoforms of this enzyme are found in the mitochondria, cytosol, and membranes, 21, 28, 32 it is unknown whether adenylate kinase contributes to the delivery of ATP to ATP-consuming sites.
Therefore, we examined the contribution of adenylate kinase to the transfer of energy-rich phosphoryls in an isolated mitochondrial/actomyosin system and in intact car-diac muscle. We report that adenylate kinase accelerates energy transfer and promotes communication between mitochondria and actomyosin, with an increased contribution to cellular phosphotransfer in the failing heart. This indicates a previously unrecognized function for this enzyme in cardiac muscle.
Materials and Methods

Isolated Actomyosin/Mitochondrial System
Mitochondria and actomyosin were isolated from rabbit (Kaunas Medical Academy, Kaunas, Lithiuania) hearts. 33, 34 Mitochondria (at 0.08 mg of protein per mL) were coincubated with actomyosin (0.5 mg/mL) in (mmol/L): sucrose 300, Tris-HCl 10 (pH 7.4), KH 2 PO 4 5, MgCl 2 3, ␣-ketoglutarate 4, and EGTA-Ca 2ϩ 3. To maintain a steady flux of high-energy phosphoryls between mitochondria and actomyosin, conditions were chosen to match ATP consumption by actomyosin ATPases with ATP production by mitochondria. The amount of actomyosin was optimal for spectrophotometric recording of contraction, which was based on changes in absorbance as an indicator of actin-myosin interaction. 35 Contraction was initiated by 100 mol/L ADP or 10 mol/L ATP and expressed as an increase in absorbance at 540 nm. 34 Mitochondrial respiration was measured by O 2 electrodes. 33 The respiratory control ratio of mitochondriaoxidizing NAD-dependent substrates was 6.98Ϯ0.41 and 11.10Ϯ0.62 (nϭ10) with and without Mg 2ϩ , respectively.
Heart Failure
To induce heart failure, dogs were paced at incremental rates during 38 days. 36, 37 Ventricular pacing was initiated at 180 bpm for 10 days. The rate was increased at 7-day intervals to 200, 210, 220, and 240 bpm. This protocol results in severe heart failure with systolic and diastolic dysfunction; reduced ejection fraction, blood pressure, and cardiac output; and elevation in left ventricular filling pressure. 36, 37 The neurohumoral profile in this model includes the activation of natriuretic peptides, renin-angiotensin, and endothelin. 36, 37 From normal and failing hearts, a segment of the left ventricular wall was excised, washed, and placed in ice-cold solution that contained 120 mmol/L NaCl and 20 mmol/L KCl. Samples were used immediately for 18 O-phosphoryl labeling or stored at Ϫ80°C for enzymatic analysis.
Enzyme Activity
Frozen samples were powdered in liquid N 2 with mortar and pestle and extracted with 150 mmol/L NaCl, 60 mmol/L Tris-HCl (pH 7.5), 5 mmol/L EDTA, 0.2% Triton X-100, 1 mmol/L PMSF, 10 g/mL leupeptin, and 1 g/mL aprotinin. Extracts were centrifuged (10 minutes, 10 000g, 4°C), and enzyme activities were measured with coupled enzyme assays and with a Beckman DU 7400 spectrophotometer at 340 nm. 8, 38 Creatine kinase activity was measured in 100 mmol/L Tris-acetate (pH 7. 39 This was supplemented with 4.5 U/mL hexokinase and 2 U/mL glucose-6-phosphate dehydrogenase, and the reaction was started with 20 mmol/L creatine phosphate. Adenylate kinase activity was measured in 100 mmol/L potassium acetate, 20 mmol/L HEPES (pH 7.5), 20 mmol/L glucose, 4 mmol/L MgCl 2 , 2 mmol/L NADP ϩ , 1 mmol/L EDTA, 1 mmol/L dithiothreitol, 4.5 U/mL hexokinase, and 2 U/mL glucose-6-phosphate dehydrogenase, and the reaction was initiated with 2 mmol/L ADP (purified by HPLC).
Phosphoryl Flux in Intact Heart Muscle
ATP turnover and phosphoryl flux through adenylate and creatine kinases were measured in intact cardiac muscle with the 18 Ophosphoryl-labeling technique. 8 This procedure is based on the incorporation of 1 18 O atom in inorganic phosphate with each act of ATP hydrolysis and the distribution of 18 O-labeled phosphoryls among high-energy phosphoryl-carrying molecules that depend on the flux via specific phosphotransfer reactions. 24, 25 Therefore, a method to quantify flux through individual enzymatic pathways is to monitor the kinetics of 18 O-phosphoryl-oxygen exchange. 22 Ventricular slices (1-to 2-mm thick) were washed 3 times, preincubated (15 minutes, 37°C) in oxygenated Krebs-Henseleit buffer (118 mmol/L NaCl; 4.7 mmol/L KCl; 1.8 mmol/L CaCl 2 ; 1.2 mmol/L MgCl 2 ; 0.5 mmol/L EDTA; 25 mmol/L NaHCO 3 ; 11 mmol/L glucose; and 10 U/L insulin, pH 7.45), and transferred into 95% O 2 /5% CO 2 saturated buffer, in which 20% to 30% of water was replaced with 18 O-containing water. After 1, 2, 4, 6, and 9 minutes of incubation, slices were freeze-clamped, pulverized in mortar with liquid N 2 , and extracted. 8 Cellular ATP, ADP, inorganic phosphate, and creatine phosphate were purified and quantified with HPLC. 30 The ␥-phosphoryl of ATP was transferred to glycerol by glycerokinase, and the ␤-phosphoryls of ATP and ADP were transferred to glycerol by a combined catalytic action of adenylate kinase and glycerokinase. The phosphoryl of creatine phosphate was transferred to ␥-ATP by creatine kinase and then to glycerol with glycerokinase. Samples that contained phosphoryls of ␥-ATP, ␤-ATP, ␤-ADP, inorganic phosphate, and creatine phosphate, as glycerol 3-phosphate, were converted to respective trimethylsilyl derivatives. The 18 O-enrichment of phosphoryls in glycerol 3-phosphates was determined with a Hewlett-Packard 5980B gas chromatograph-mass spectrometer operated in the select ion-monitoring mode. 30 Total cellular ATP turnover was estimated from the sum of the total number of 18 O atoms that appeared in phosphoryl-containing metabolites and orthophosphate. 8, 24 The net rate of adenylate kinase-catalyzed phosphotransfer was estimated from the initial rate of appearance of 18 O-containing ␤-phosphoryls in ADP and ATP. 8 The net rate of creatine kinase-catalyzed phosphoryl transfer was determined from the initial rate of appearance of creatine phosphate species with 18 O-labeled phosphoryls. 8, 24 
Statistical Analysis
Data are expressed as meanϮSEM. Student t test for unpaired samples was used for statistical analysis, and a difference at PϽ0.05 was considered significant.
Results
Adenylate Kinase-Mediated Communication Between Isolated Actomyosin and Mitochondria
Isolated mitochondrial (nϭ5) and actomyosin (nϭ10) preparations possessed endogenous adenylate kinase activity of 469Ϯ49 and 83Ϯ5 nmol ATP ⅐ min Ϫ1 ⅐ mg Ϫ1 protein, respectively, and were coincubated at protein concentrations in which the mitochondrial/myofibrillar ratio of adenylate kinase activity was Ϸ1:1. When ADP, a substrate of adenylate kinase and mitochondria, was added to the mitochondrial/ actomyosin system, actomyosin contraction was promoted, as observed by increased absorbance of the actomyosin complex ( Figure 1A , curve 1). Treatment with Ap 5 A 39 slowed the development and decreased the amplitude of actomyosin contraction ( Figure 1A) . The rate and amplitude of contraction were 150Ϯ25 absorbance units (AU) Ϫ3 ⅐ min Ϫ1 and 0.089Ϯ0.004 AU in the absence versus 21Ϯ3 AU Ϫ3 ⅐ min
Ϫ1
and 0.015Ϯ0.001 AU in the presence of Ap 5 A (nϭ10; Figure  1B ). Values measured in the presence of Ap 5 A were significantly lower than those obtained in the absence of the adenylate kinase inhibitor (PϽ0.001). The addition of exogenous, purified, adenylate kinase (7 U/mL) significantly (PϽ0.001) accelerated the rate (325Ϯ49 AU Ϫ3 ⅐ min
) and increased the amplitude (0.138Ϯ0.006 AU) of contraction ( Figure 1A and 1B); both effects were inhibited by Ap 5 A (not shown). Thus, adenylate kinase activity promotes actomyosin contraction, which could be due to local regeneration of ATP and/or increased transfer of ATP from mitochondria to myosin ATPases.
To distinguish between these 2 interrelated functions of adenylate kinase, the local regeneration of ATP versus the spatially-directed transfer of nucleotides between mitochondria and actomyosin, 4, 23 we examined whether adenylate kinase activity promotes contraction under conditions in which ATP regeneration is minimal and diffusional limitations exist for adenine nucleotide exchange between mitochondria and actomyosin. In the absence of mitochondria, when actomyosin was induced to contract by the addition a low concentration of ATP (10 mol/L), the rate and amplitude of contraction were 167Ϯ6 AU Ϫ3 ⅐ min Ϫ1 and 0.051Ϯ0.003 AU (nϭ5; Figure 2A ). In the continued absence of mitochondria and presence of Ap 5 A, the rate and amplitude of contraction were 161Ϯ6 AU Ϫ3 ⅐ min Ϫ1 and 0.043Ϯ0.002 AU (nϭ8; Figure 2A ). Values obtained in the absence and presence of the adenylate kinase inhibitor were not significantly different (PϾ0.05), which suggested that in the absence of mitochondria and at a low concentration of ATP, the ATP-regenerating function of adenylate kinase is minimal. Additional mitochondria in the continued presence of Ap 5 A accelerated the rate of contraction to 216Ϯ5 AU Ϫ3 ⅐ min Ϫ1 and increased the amplitude of contraction to 0.065Ϯ0.002 AU (PϽ0.05, nϭ8; Figure 2 ), which suggested that to some extent energy can be transferred by simple diffusion or other phosphotransfer systems in the absence of adenylate kinasecatalyzed phosphotransfer. In the presence of mitochondria but absence of Ap 5 A, the rate and amplitude of contraction were 282Ϯ9 AU Ϫ3 ⅐ min Ϫ1 and 0.086Ϯ0.003 AU (nϭ8); these values are significantly higher than those measured in the presence of Ap 5 A (PϽ0.001; Figure 2A ). Thus, in the reconstituted system, adenylate kinase promotes the delivery of ATP from mitochondria to actomyosin ATPases even in the absence of a major effect on ATP regeneration.
To assess whether adenylate kinase contributes to feedback communication between actomyosin and mitochondria, mitochondrial respiration was measured in the absence and 
Adenylate Kinase-Catalyzed Phosphotransfer in Intact Myocardium
The contribution of adenylate kinase to cellular phosphotransfer was assessed in myocardial samples with 18 Ophosphoryl labeling. The kinetics of 18 O-labeled phosphoryl appearance in ␥-ATP reflects cellular ATP turnover rate. 24 The total ATP turnover rate, which is determined from the sum of 18 O atoms inserted into phosphoryl-containing cellular metabolites, was 37.5Ϯ1.4 nmol ATP ⅐ min Ϫ1 ⅐ mg Ϫ1 protein (nϭ5; Figure 3A and 3B). Adenylate kinase catalyzes ␤-ATP 18 O-labeling. 8 The net adenylate kinase-catalyzed phosphotransfer rate in the direction of ADP formation, was 3.72Ϯ0.3 nmol ADP ⅐ min Ϫ1 ⅐ mg Ϫ1 protein (nϭ5; Figure 3A and 3B). This value corresponds to Ϸ10% of the total ATP turnover rate. The rate of 18 O-labeling of creatine phosphate reflects creatine kinase-catalyzed phosphotransfer. 8 The net creatine phosphate-catalyzed phosphotransfer rate was 32.4Ϯ1.6 nmol CrP ⅐ min Ϫ1 ⅐ mg Ϫ1 protein (nϭ5) or 89% of the total ATP turnover rate ( Figure 3A and 3B) . Thus in intact myocardium, adenylate kinase can transfer high-energy phosphoryls that contribute to cellular phosphotransfer.
Increased Contribution of Adenylate Kinase in Heart Failure
The kinetics of 18 O-labeling of phosphoryls in ␥-ATP, creatine phosphate, and ␤-ATP in failing hearts are presented in Figure 3C . The overall ATP turnover rate (42.1Ϯ1.5 nmol ATP ⅐ min Ϫ1 ⅐ mg Ϫ1 protein, nϭ6) was essentially unchanged (PϾ0.05) when compared with controls ( Figure 3A) . Although the initial rate of 18 O-labeled phosphoryl appearance in ␥-ATP was similar in the 2 groups, subsequent 18 O incorporation was reduced in the failing myocardium and approached saturation faster, which suggested that in heart failure, a smaller pool of ATP is involved in energy turnover ( Figure 3A through 3C ). Thus at 6 minutes of 18 O-labeling, the pool size of labeled ␥-ATP was lower by 20% (PϽ0.05) in the failing myocardium compared with normal myocardium ( Figure 3A through 3C) . The failing heart also displayed a marginal decrease in ATP levels to 25 Figure 3D ). In failing hearts, the contribution of creatine kinase to the overall ATP turnover rate decreased to Ϸ40%. But, adenylate kinase-catalyzed ␤-ATP 18 O-labeling increased. The rate of adenylate kinase-catalyzed phosphotransfer increased to 8.71Ϯ0.4 nmol ⅐ mg Ϫ1 protein ⅐ min
Ϫ1
(nϭ6) or 134% compared with controls (PϽ0.001). In the failing myocardium, the contribution of adenylate kinase to the overall ATP turnover doubled and was 21% of the total ATP turnover rate.
To assess whether changes in phosphoryl fluxes are related to altered enzyme activities, specific activities of adenylate and creatine kinase were measured. In control hearts (nϭ6), the activities of adenylate and creatine kinases were 537Ϯ18 and 2551Ϯ64 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 protein, respectively. In extracts from failing hearts (nϭ8), specific activities of adenylate and creatine kinases were 422Ϯ16 and 1791Ϯ42 nmol ⅐ min Ϫ1 ⅐ mg Ϫ1 protein, respectively. These are significant (PϽ0.001) decreases in specific activities when compared with controls: 21% for adenylate and 30% for creatine kinase. Thus, the increase in phosphoryl flux through adenylate kinase in failing hearts occurs despite a reduction in the total activity of this enzyme.
Discussion
In the heart, adenylate kinase has been implicated in the control of oxidative phosphorylation, 26, 33, 40 export of highenergy phosphoryls from mitochondria, 21 and regulation of ATP-sensitive K ϩ channels. 3, 28, 41 In this study, we show that adenylate kinase also facilitates the transfer of high-energy phosphoryls and signal communication between mitochondria and actomyosin. This was demonstrated in an isolated actomyosin/mitochondria system and in intact myocardium. The contribution of adenylate kinase to the overall cellular ATP metabolic flux significantly increased during heart failure when creatine kinase-dependent phosphotransfer was compromised. Thus, this study establishes the role for adenylate kinase in supporting myocardial energy flux.
In the reconstituted actomyosin/mitochondrial system devoid of other ATP-regenerating and ATP-consuming cellular components, 34 adenylate kinase-catalyzed phosphotransfer, which can occur in mitochondria and myofibrils, 33, 42 accelerated the rate and increased the amplitude of contraction. This effect was suppressed by Ap 5 A, 39 which has no direct effect on myosin ATPases or mitochondria. 43, 44 A dependence of contraction on adenylate kinase activity could be due to local regeneration of ATP and/or transfer of nucleotides between mitochondria and actomyosin. 4, 25 When conditions were able to minimize the ATP-regenerating function of adenylate kinase at low concentrations of ADP or ATP, the effect of adenylate kinase-catalyzed phosphotransfer required both actomyosin and mitochondria. In the absence of mitochondria, the ATP-regenerating function of adenylate kinase is limited by the accumulation of AMP. 33, 40 In the presence of mitochondria, AMP is rephosphorylated to ATP and transferred back to the myofibrils, which allows for continuous phosphoryl flux. 4 Yet, in the absence of adenylate kinase activity, the exchange of energy-rich nucleotides by simple diffusion is insufficient to sustain a maximal rate of contraction. But, combined actomyosin/mitochondrial adenylate kinase activities promoted actomyosin contraction and mitochondrial respiration, which indicated an adenylate kinase-dependent flow of high-energy phosphoryls from mitochondria to actomyosin. These findings fulfill criteria for adenylate kinase-catalyzed phosphotransfer to process cellular signals associated with ATP production and use in cardiomyocytes, as proposed previously for noncardiac tissues. 3, 4, 8, 22, 30 In intact cardiac muscle, the total ATP turnover rate (37.5 nmol ATP ⅐ min Ϫ1 ⅐ mg Ϫ1 protein) was obtained directly from 18 O measurements and was within the range (27 to 54 nmol ATP ⅐ min Ϫ1 ⅐ mg Ϫ1 protein) of that calculated 24 from O 2 consumption rates in resting dog myocardium. 45, 46 The net adenylate kinase-catalyzed phosphotransfer rate accounted for 10% of the total ATP turnover rate, compared with 3% to 5% in resting skeletal muscle, 8, 22 which suggested possible tissue-specific differences in the contribution of adenylate kinase to cellular phosphotransfer. In this experiment, creatine kinase phosphotransfer contributed 89% to the total ATP turnover rate. Thus, in the heart, the majority of high-energy phosphoryls are transferred through combined actions of creatine and adenylate kinases.
In the failing myocardium, the overall ATP turnover rate was similar to that in the normal heart, which supported the notion that ATP levels and ATPase activity may not change with the progression of disease. 1 In fact, we did not observe a significant decrease in the ATP concentration in the failing myocardium. However, changes in the kinetics of ␥-ATP 18 O-labeling suggest that in heart failure a smaller pool of ATP is actively involved in cellular energetics. This can result from altered compartmentation and/or deficient phosphotransfer of adenine nucleotides. 7, 10, 11 Present data show a reduction (by 52%) in creatine kinase-catalyzed phosphotransfer in pacing-induced heart failure and a decreased (from 89% to 40%) contribution of creatine kinase to the overall ATP turnover. This correlates with previous studies that have, in other models of heart failure, also implicated a deficiency in creatine kinase-catalyzed energy transfer. 15, 47 The new information provided by this study relates to the significance of adenylate kinase-catalyzed phosphotransfer that increased by Ϸ134% in heart failure. Consequently, the contribution of adenylate kinase to total ATP turnover rate doubled to 21%. Such increase in adenylate kinase-catalyzed phosphotransfer could support cellular energetics of a failing heart.
Compensation provided by adenylate kinase was only partial. The sum of phosphotransfers mediated through creatine and adenylate kinases contributed to Ϸ100% of the total ATP turnover rate in normal hearts but only 60% to 65% in failing hearts, which left a 35% to 40% phosphotransfer deficit. This term refers to a deficit in enzyme-mediated phosphotransfer in which remaining phosphoryls are delivered through a less-efficient mechanism, such as simple diffusion and/or the glycolytic pathway. 3, 4 Although in normal muscle an acute suppression of creatine kinase activity is well compensated through increased adenylate kinase phosphotransfer, 8 the compensatory potential of adenylate kinase in diseased heart appears to be reduced. Previously, in ischemia-injured myocardium, a diminished activity of adenylate kinase has been reported to reduce the export of high-energy phosphoryls from mitochondria. 48 The specific activity of adenylate kinase reflects the flux capacity of this enzyme. Therefore, a drop in flux capacity, as observed here in the failing myocardium, may limit the compensatory potential of adenylate kinase-dependent phosphotransfer. This could be due to a decrease in adenylate kinase expression and/or altered enzyme regulation. Because our preliminary results, which were performed with Western blot analysis to detect adenylate kinase level in ventricular samples, do not indicate a significant decrease in protein levels of adenylate kinase in heart failure, other mechanisms should be considered including changes in cardiac levels of Ap 5 A that may occur under metabolic stress. 49 In summary, the current study, performed in the isolated mitochondria/actomyosin system and intact ventricular tissue, identifies a role for adenylate kinase in the transfer of energy and feedback communication between mitochondria and myofibrils in the heart. Although experimental systems permit the demonstration of phosphotransfer dynamics that are independent from variations due to muscle contraction, the functional integrity of cardiac muscle is only partially preserved, which warrants additional studies to establish the full role of adenylate kinase in a beating heart. A coordinated action of mitochondrial and cytosolic isoforms of adenylate kinase, which are encoded by separate genes and directed to different subcellular compartments, 32 would provide a mechanism to transfer 2 high-energy phosphoryls within the ATP molecule ( Figure 4) . The exclusive property of adenylate kinase to transfer the energy of the ␤-phosphoryl of ATP, which is energetically equivalent to the commonly employed ␥-phosphoryl, doubles the energetic potential of the ATP molecule and halves the diffusional resistance of the cytosol for energy transfer. 4, 50 Such phosphotransfer function renders adenylate kinase an important component for optimal myocardial bioenergetics. In particular, adenylate kinase could serve a compensatory role in heart failure. Thus, the promotion of adenylate kinase-mediated phosphotransfer could provide a novel strategy targeted at improving the energetic status of the failing heart. 
